Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Logigian EL, Martens WB, Moxley RT 4th, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, Moxley RT 3rd.

Neurology. 2010 May 4;74(18):1441-8. doi: 10.1212/WNL.0b013e3181dc1a3a.

2.

Evoked myotonia can be "dialed-up" by increasing stimulus train length in myotonic dystrophy type 1.

Logigian EL, Twydell P, Dilek N, Martens WB, Quinn C, Wiegner AW, Heatwole CR, Thornton CA, Moxley RT 3rd.

Muscle Nerve. 2010 Feb;41(2):191-6. doi: 10.1002/mus.21481.

3.

Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).

Moxley RT 3rd, Logigian EL, Martens WB, Annis CL, Pandya S, Moxley RT 4th, Barbieri CA, Dilek N, Wiegner AW, Thornton CA.

Muscle Nerve. 2007 Sep;36(3):320-8.

PMID:
17587223
4.

Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1.

Logigian EL, Blood CL, Dilek N, Martens WB, Moxley RT 4th, Wiegner AW, Thornton CA, Moxley RT 3rd.

Muscle Nerve. 2005 Jul;32(1):35-42.

PMID:
15880468
5.

Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.

Logigian EL, Moxley RT 4th, Blood CL, Barbieri CA, Martens WB, Wiegner AW, Thornton CA, Moxley RT 3rd.

Neurology. 2004 Apr 13;62(7):1081-9.

PMID:
15079005
6.
7.

Accuracy of motor responses in subjects with and without control of antagonist muscle.

Wierzbicka MM, Wiegner AW.

J Neurophysiol. 1996 Jun;75(6):2533-41.

PMID:
8793762
8.

Discharge properties of single motor units in patients with spinal cord injuries.

Wiegner AW, Wierzbicka MM, Davies L, Young RR.

Muscle Nerve. 1993 Jun;16(6):661-71.

PMID:
8502264
9.

Can basic science help improve arm function in C5 tetraplegia?

Wiegner AW.

J Am Paraplegia Soc. 1993 Apr;16(2):75. No abstract available.

PMID:
8496696
10.

Portable system for quantifying motor abnormalities in Parkinson's disease.

Ghika J, Wiegner AW, Fang JJ, Davies L, Young RR, Growdon JH.

IEEE Trans Biomed Eng. 1993 Mar;40(3):276-83.

PMID:
8335331
11.

Variation in firing order of human soleus motoneurons during voluntary and reflex activation.

Davies L, Wiegner AW, Young RR.

Brain Res. 1993 Jan 29;602(1):104-10.

PMID:
8448646
12.

Kinematic models and human elbow flexion movements: quantitative analysis.

Wiegner AW, Wierzbicka MM.

Exp Brain Res. 1992;88(3):665-73.

PMID:
1587325
13.

Treatment of spasticity with botulinum toxin.

Borodic GE, Ferrante R, Wiegner AW, Young RR.

Ann Neurol. 1992 Jan;31(1):113. No abstract available.

PMID:
1543342
14.

Effects of weak antagonist on fast elbow flexion movements in man.

Wierzbicka MM, Wiegner AW.

Exp Brain Res. 1992;91(3):509-19.

PMID:
1483523
15.

Abnormal most-rapid isometric contractions in patients with Parkinson's disease.

Wierzbicka MM, Wiegner AW, Logigian EL, Young RR.

J Neurol Neurosurg Psychiatry. 1991 Mar;54(3):210-6.

16.

Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy.

Borodic GE, Cozzolino D, Ferrante R, Wiegner AW, Young RR.

Ophthalmic Plast Reconstr Surg. 1991;7(1):54-60.

PMID:
1708272
17.

Effects of muscle thixotropy on afferent activity in the hindlimb of the rat.

Warner JE, Wiegner AW.

Exp Physiol. 1990 Mar;75(2):223-30.

18.

Motor unit synchronization in physiologic, enhanced physiologic, and voluntary tremor in man.

Logigian EL, Wierzbicka MM, Bruyninckx F, Wiegner AW, Shahahi BT, Young RR.

Ann Neurol. 1988 Mar;23(3):242-50.

PMID:
2967666
19.

Papillary muscle structure-function relations in the aging spontaneously hypertensive rat.

Bing OH, Wiegner AW, Brooks WW, Fishbein MC, Pfeffer JM.

Clin Exp Hypertens A. 1988;10(1):37-58.

PMID:
3349638
20.

A method for assessing significance of peaks in cross-correlation histograms.

Wiegner AW, Wierzbicka MM.

J Neurosci Methods. 1987 Dec;22(2):125-31.

PMID:
3437775

Supplemental Content

Loading ...
Support Center